Nan Fung Group Holdings’s Recursion Pharmaceuticals RXRX Stock Holding History

Nan Fung Group Holdings’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Hold	595,287	–	–	1.66%	16
2026 Q1	$1.83M	Hold	595,287	–	–	1.51%	17
2025 Q4	$2.43M	Hold	595,287	–	–	2.18%	13
2025 Q3	$2.91M	Sell	595,287 -69,323	-10%	-$364K	4.87%	8
2025 Q2	$3.36M	Hold	664,610	–	–	5.3%	7
2025 Q1	$3.52M	Hold	664,610	–	–	2.87%	15
2024 Q4	$4.49M	Buy	+664,610	New	+$4.47M	3.84%	10

Other funds holding RXRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nan Fung Group Holdings's RXRX Position: Q2 2026 in Review

Nan Fung Group Holdings held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 595,287 shares worth $2.18M. The position accounts for 1.66% of the portfolio, ranked #16.

Nan Fung Group Holdings first reported a position in RXRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.49M in Q4 2024. 342 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

Nan Fung Group Holdings held 595,287 shares of Recursion Pharmaceuticals worth $2.18M as of Q2 2026.
Nan Fung Group Holdings left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
Recursion Pharmaceuticals made up 1.66% of Nan Fung Group Holdings's portfolio in Q2 2026, its #16 holding.
Nan Fung Group Holdings first reported a position in Recursion Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Nan Fung Group Holdings's Recursion Pharmaceuticals position peaked at $4.49M in Q4 2024.
342 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.